Cardiorenal syndrome: pathogenesis, clinical picture

Cover Page


Cite item

Full Text

Abstract

Owing to the commonality of a number of pathogenetic mechanisms, cardiovascular system and kidneys diseases often occur together, mutually exacerbating the severity. The circulatory system and the circulating plasma amount are in many respects regulated by the kidneys functional activity. The parameters of systemic hemodynamics and left ventricular function influence on renal function. The discovery of the mechanisms of renal function impairment influence on the heart state and activity contribute to a fuller understanding of the two systems mutual influence. Currently it is recognized that the frequent combination of cardiovascular and renal diseases based primarily on common pathogenic mechanisms of both forms of pathology and their mutually aggravating influence. In accordance with the modern classification there are five types of cardiorenal syndrome: (1) acute renal dysfunction amid acute-onset cardiac dysfunctions; (2) chronic renal dysfunction due to chronic cardiac pathology; (3) acute cardiac dysfunctions due to acute renal impairment; (4) long-term cardiac and cardiovascular system disorders in patients with chronic renal dysfunction; (5) combined cardiorenal pathology due to other organs and systems dysfunction. The clinical significance of this disease is that doctors of various specialties might face it in their practice: physicians, cardiologists, endocrinologists, resuscitators. Cardiorenal syndrome diagnosis is based on patient constant monitoring in several ways, including laboratory and instrumental indicators, allowing timely suspect the initial stages of this pathology development. This increases the research relevance in this field and clinical value of obtained through them practical conclusions and recommendations, reflected in a number of international documents.

About the authors

N A Tsibul’kin

Kazan State Medical Academy

Author for correspondence.
Email: diazkzn@mail.ru

A A Novozhilova

Kazan State Medical Academy

Email: diazkzn@mail.ru

D M Khakimova

Kazan (Volga region) Federal University

Email: diazkzn@mail.ru

References

  1. Авдошина С.В., Ефремовцева М.А., Виллевальде С.В., Кобалава Ж.Д. Острый кардиоренальный синдром: эпидемиология, патогенез, диагностика и лечение. Клин. фармакол. и терап. 2013 (4): 11-17.
  2. Кобалава Ж.Д., Виллевальде С.В., Ефремовцева М.А. Основы кардиоренальной медицины. Под ред. Ж.Д. Кобалава, В.С. Моисеева. М.: ГЭОТАР-Медиа. 2014; 256 с.
  3. Кобалава Ж.Д., Виллевальде С.В., Клименко А.С. и др. Острый кардиоренальный синдром у больного с декомпенсацией хронической сердечной недостаточности. Клин. нефрол. 2012 (3): 62-68.
  4. Кобалава Ж.Д., Ефремовцева М.А., Виллевальде С.В. Кардиоренальные синдромы. Клин. нефрол. 2011 (6): 9-15.
  5. Моисеев В.С., Мухин Н.А., Смирнов А.В. и др. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио-нефропротекции. Рос. кардиол. ж. 2014 (8): 7-37.
  6. Сигитова О.Н., Архипов Е.В. Хроническая болезнь почек: новое в классификации, диагностике, нефропротекции. Вестн. соврем. клин. мед. 2014; 7 (1): 103-106.
  7. Abbas N.A., Jhon R.I., Webb M.C. et al. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin. Chem. 2005; 51: 2059-2066. http://dx.doi.org/10.1373/clinchem.2005.055665
  8. Avdoshina S., Klimenko A., Villevalde S. et al. Prevalence and prognostic value of acute kidney injury with non-ST-elevation acute coronary syndrome. J. Hypertens. 2013; 31: Abs. PP.04.123.
  9. Bagshaw S.M., Lapinsky S., Dial S. et al. Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive. Car. Med. 2009; 35: 871-881. http://dx.doi.org/10.1007/s00134-008-1367-2
  10. Boerrigter G., Hocher B., Lapp H. Changes in renal function in congestive heart failure. Curr. Heart Fail. Rep. 2013; 10 (4): 285-295. http://dx.doi.org/10.1007/s11897-013-0170-8.
  11. Bosselmann H., Tonder N., Soletormos G. et al. Influence of renal impairment on myocardial function in outpatients with systolic heart failure: an echocardiographic and cardiac biomarker study. Int. J. Cardiol. 2014; 177 (3): 942-948. http://dx.doi.org/10.1016/j.ijcard.2014.09.202
  12. Bouquegneau A., Krzesinski J., Delanaye P. et al. Biomarkers and physiopathology in the cardiorenal syndrome. Clin. Chim. Acta. 2015; 443: 100-107. http://dx.doi.org/10.1016/j.cca.2014.10.041
  13. Buglioni A., Burnett J. Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators. Clin. Chim. Acta. 2015; 443: 3-8. http://dx.doi.org/10.1016/j.cca.2014.10.027
  14. Campbell R.C., Sui S., Filippatos G. et al. Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study. Nephrol. Dial. Transplant. 2009; 24:186-193. http://dx.doi.org/10.1093/ndt/gfn445
  15. Cohen L. The cardiorenal syndrome: pathophysiologic crosstalk, outcomes, and treatment targets. Cardiovasc. Hematol. Disord. Drug Targets. 2014; 14 (3): 170-176. http://dx.doi.org/10.2174/1871529X14666140701100913
  16. Damman K., Testani J. The kidney in heart failure: an update. Eur. Heart J. 2015. [Epub. ahead of print]. http://dx.doi.org/10.1093/eurheartj/ehv010
  17. Dzau V. The cardiovascular continuum and renin-angiotensin-aldosterone system blockade. J. Hypertens. 2005; 23 (suppl. 1): S9-S17.
  18. Fabbian F., De Giorgi A., Pala M. et al. Renal dysfunction and all-cause mortality in cardio-renal syndrome: calculation of glomerular filtration rate is crucial, independent of the equation. Int. J. Cardiol. 2013; 170 (1): e11-е13.
  19. Foley R., Murray A., Li S. et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999. J. Am. Soc. Nephrol. 2005; 16: 489-495. http://dx.doi.org/10.1681/ASN.2004030203
  20. Fonarow G.C., Stough W.G., Abraham W.T. et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry. J. Am. Coll. Cardiol. 2007; 50: 768-777. http://dx.doi.org/10.1016/j.jacc.2007.04.064
  21. Hanna E., Hanna D. Acute heart failure: acute cardiorenal syndrome and role of aggressive decongestion. Clin. Cardiol. 2014; 37 (12): 773-778. http://dx.doi.org/10.1002/clc.22337
  22. Izzard A. Aortic pulsatility and cardio-renal syndrome: renal heamodyamics and the microvasculature. J. Hypertens. 2014; 32 (8): 1580-1581. http://dx.doi.org/10.1097/HJH.0000000000000266
  23. Jonsson S., Agic M., Narfstrom F. et al. Renal neurohormonal regulation in heart failure decompensation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2014; 307 (5): R493- R497.
  24. Latchamsetty R., Fang J., Kline-Rogers E. et al. Prognostic value of transient and sustained increase in in-hospital creatinine on outcomes of patients admitted with acute coronary syndrome. Am. J. Cardiol. 2007; 99 (7): 939-942. http://dx.doi.org/10.1016/j.amjcard.2006.10.058
  25. Lekawanvijit S., Krum H. Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins. J. Physiol. 2014; 592 (Pt. 18): 3969-3983. http://dx.doi.org/10.1113/jphysiol.2014.273078
  26. McCullough P.A., Li S., Jurkovitz C.T. et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am. J. Kidney Dis. 2008; 51 (4, suppl. 2): 38-45. http://dx.doi.org/10.1053/j.ajkd.2007.12.017
  27. Mehta R.L., Kellum J.A., Shah S.V. et al. Acute Kidney Injury Network (AKIN): report of an initiative to improve outcomes in acute kidney injury. Crit. Care. 2007; 11: R31.30. http://dx.doi.org/10.1186/cc5713
  28. Nunez J., Minana G., Santas E. et al. Rev Cardiorenal syndrome in acute heart failure: revisiting paradigms. Esp. Cardiol. (Engl. Ed.). 2015; 68 (5): 426-435.
  29. Onuigbo M. RAAS inhibition and cardiorenal syndrome. Curr. Hypertens. Rev. 2014; 10 (2): 107-111. http://dx.doi.org/10.2174/1573402111666141231144228
  30. Palomo-Pinon S., Mora-Villalpando C., Del Carmen Prado-Uribe M. et al. Inflammation and myocardial damage markers influence loss of residual renal function in peritoneal dialysis patients. Arch. Med. Res. 2014; 45 (6): 484-488. http://dx.doi.org/10.1016/j.arcmed.2014.07.003
  31. Pimentel R., Couto M., Laszczynska O. et al. Prognostic value of worsening renal function in outpatients with chronic heart failure. Eur. J. Intern. Med. 2014; 25 (7): 662-668. http://dx.doi.org/10.1016/j.ejim.2014.06.002
  32. Ronco C., Bellomo R., McCullough P.A. Cardiorenal syndromes in critical care. Contrib. Nephrol. Basel, Karge. 2010; 165: 112-128. http://dx.doi.org/10.1159/isbn.978-3-8055-9473-8
  33. Ronco C., Cruz D.N. Biomarkers in cardio-renal syndromes (Rassegna). Altri. Contributi Ligand. Assay. 2009; 14 (4): 340-349.
  34. Ronco C., McCullough P., Anker S. et al. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur. Heart. J. 2010; 31: 703-711. http://dx.doi.org/10.1093/eurheartj/ehp507
  35. Valika A., Costanzo M. The acute cardiorenal syndrome type I: considerations on physiology, epidemiology, and therapy. Curr. Heart Fail. Rep. 2014; 11 (4): 382-392. http://dx.doi.org/10.1007/s11897-014-0224-6

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2016 Tsibul’kin N.A., Novozhilova A.A., Khakimova D.M.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies